Please Wait

Applying Filters...

CDMO Activity Tracker: Veranova, ChemExpress invest in ADC facilities; Cohance to set up oligonucleotide facility in India

Data Compilation
#PharmaFlow

Pipeline Prospector October 2025: Novartis to buy Avidity for US$ 12 bn; FDA approves Bayer’s med to treat hot flashes

Stock Recap
#PipelineProspector

Tazobactam Sodium

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

38 API Suppliers, 17 USDMF, 10 JDMF, 2 EU WC, 2 KDMF, 8 NDC API, 9 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

11 Drugs in Development

11 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

234 FDF Dossiers, 60 FDA Orange Book, 101 Europe, 12 South Africa, 61 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - EQ 40MG BASE/ML;EQ 5MG BASE/ML, INJECTABLE;INJECTION - EQ 4GM BASE/100ML;EQ 500MG BASE/100ML, INJECTABLE;INJECTION - EQ 60MG BASE/ML;EQ 7.5MG BASE/ML

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 1 Pfanstiehl, 5 Kirsch Pharma, 3 Actylis, 1 Pluviaendo, 4 Roquette

EXCIPIENTS BY APPLICATIONS

10 Parenteral, 2 API Stability Enhancers, 2 Fillers, Diluents & Binders, 2 Thickeners and Stabilizers

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 44 News #PharmaBuzz

GLOBAL SALES INFORMATION

23 US Medicaid Prescriptions, 17 Regulatory FDF Prices, 12 Annual Reports

MARKET PLACE

15 APIs, 5 FDF Dossiers

PATENTS & EXCLUSIVITIES

26 US Patents, 1 US Exclusivities, 6 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 Others

4 Others

$ Xls download

Filters

Log in to access your PharmaMiles and download the data

Last Updated on PharmaCompass	Virtual Booth	Country	Name of the Firm	Written Confirmation No.	Product Name	Issue Date	Valid Till	Address of the Firm
13/10/2025	Sterile India Pvt. Ltd	India	Sterile India Pvt. Ltd	WC-0624	Tazobactam Sodium (Sterile) IН	2025-10-07	2028-10-06	Plot No 73, Sector-53, Phase-V, HSIIDC, KUNDLI, Sonipat, Haryana, India, 131028
07/10/2025	Sterile India Pvt. Ltd	India	M/s Sterile India Pvt Ltd	WC-0378	Tazobactam Sodium Sterile IH	2025-09-24	2028-07-06	Plot No. 100, 118G, Sec-56, Phase-IV, HSIIDC, Kundli, Sonipat, Haryana, INDIA Kundli, Sonipat-131028, Haryana India

Contact us
to update this info

Tazobactam Sodium

Tazobactam Sodium

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

38 API Suppliers

17 USDMF

10 JDMF

2 EU WC

2 KDMF

8 NDC API

9 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

11 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

234 FDF Dossiers

60 FDA Orange Book

101 Europe

12 South Africa

61 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - EQ 40MG BASE/ML;EQ 5MG BASE/ML

INJECTABLE;INJECTION - EQ 4GM BASE/100ML;EQ 500MG BASE/100ML

INJECTABLE;INJECTION - EQ 60MG BASE/ML;EQ 7.5MG BASE/ML

RELATED EXCIPIENT COMPANIES

1 SPI Pharma

1 Pfanstiehl

5 Kirsch Pharma

3 Actylis

1 Pluviaendo

4 Roquette

EXCIPIENTS BY APPLICATIONS

10 Parenteral

2 API Stability Enhancers

2 Fillers, Diluents & Binders

2 Thickeners and Stabilizers

DIGITAL CONTENT

1 Data Compilation #PharmaFlow

44 News #PharmaBuzz

GLOBAL SALES INFORMATION

23 US Medicaid Prescriptions

17 Regulatory FDF Prices

12 Annual Reports

MARKET PLACE

15 APIs

5 FDF Dossiers

PATENTS & EXCLUSIVITIES

26 US Patents

1 US Exclusivities

6 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 Others

Filters

INJECTABLE;INJECTION - EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons